注:本產(chǎn)品僅用于科研,不可用于臨床
生物活性 | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target |
| ||||||||||||||||
體外研究 (In Vitro) | ATP (5 mM; 1 hour) co-treatment with LPS (1 μg/mL) has a synergistic effect on the activation of the NLRP3 inflammasome in HGFs[3]. MCE has not independently confirmed the accuracy of these methods. They are for reference only. | ||||||||||||||||
體內(nèi)研究 (In Vivo) | ATP (50 mg/kg; i.p.) protects mice against bacterial infection in vivo[4]. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
| ||||||||||||||||
分子量 | 507.18 | ||||||||||||||||
性狀 | Solid | ||||||||||||||||
Formula | C10H16N5O13P3 | ||||||||||||||||
CAS 號(hào) | 56-65-5 | ||||||||||||||||
中文名稱 | 腺苷三磷酸 | ||||||||||||||||
結(jié)構(gòu)分類 |
| ||||||||||||||||
來(lái)源 |
widespread | ||||||||||||||||
運(yùn)輸條件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
儲(chǔ)存方式 |
| ||||||||||||||||
溶解性數(shù)據(jù) | In Vitro: H2O : ≥ 100 mg/mL (197.17 mM) * "≥" means soluble, but saturation unknown. 配制儲(chǔ)備液
* 請(qǐng)根據(jù)產(chǎn)品在不同溶劑中的溶解度選擇合適的溶劑配制儲(chǔ)備液;一旦配成溶液,請(qǐng)分裝保存,避免反復(fù)凍融造成的產(chǎn)品失效。 In Vivo: 請(qǐng)根據(jù)您的實(shí)驗(yàn)動(dòng)物和給藥方式選擇適當(dāng)?shù)娜芙夥桨?。以下溶解方案都?qǐng)先按照 In Vitro 方式配制澄清的儲(chǔ)備液,再依次添加助溶劑: ——為保證實(shí)驗(yàn)結(jié)果的可靠性,澄清的儲(chǔ)備液可以根據(jù)儲(chǔ)存條件,適當(dāng)保存;體內(nèi)實(shí)驗(yàn)的工作液,建議您現(xiàn)用現(xiàn)配,當(dāng)天使用; 以下溶劑前顯示的百
|